World PulseNow
Newsletter

Pfizer wins early US approval of bid to take over obesity biotech Metsera

Financial Times•Friday, October 31, 2025 at 8:38:27 PM
PositiveFinancial Markets
Pfizer wins early US approval of bid to take over obesity biotech Metsera
Pfizer has received early approval from US regulators for its bid to acquire the obesity biotech company Metsera, marking a significant step in the ongoing competition with Novo Nordisk for dominance in the weight loss market. This move not only highlights Pfizer's commitment to expanding its portfolio in the obesity treatment sector but also signals potential regulatory support for innovative solutions in public health. As obesity rates continue to rise, this acquisition could lead to new advancements in treatment options, benefiting millions.
— Curated by the World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Recommended Readings
Pfizer sues Metsera and Novo Nordisk over merger agreement breach
Investing.coman hour ago
Pfizer sues Metsera and Novo Nordisk over merger agreement breach
NegativeFinancial Markets
Pfizer has filed a lawsuit against Metsera and Novo Nordisk, alleging a breach of their merger agreement. This legal action highlights the complexities and challenges in the pharmaceutical industry, particularly as companies navigate partnerships and mergers. The outcome of this case could have significant implications for future collaborations in the sector.
Read full article
via Investing.com
Pfizer gets US antitrust clearance for Metsera deal
Investing.coman hour ago
Pfizer gets US antitrust clearance for Metsera deal
PositiveFinancial Markets
Pfizer has received antitrust clearance from the U.S. government for its acquisition of Metsera, a significant step that allows the pharmaceutical giant to proceed with the deal. This approval is crucial as it not only strengthens Pfizer's portfolio but also enhances its capabilities in the competitive healthcare market. The clearance reflects confidence in Pfizer's commitment to innovation and patient care, making this a noteworthy development in the industry.
Read full article
via Investing.com
The Potholes On The Road To American Reindustrialization
Forbes2 hours ago
The Potholes On The Road To American Reindustrialization
PositiveFinancial Markets
The U.S. is on the brink of a significant turnaround in its industrial sector, with various forces coming together to combat industrial decline. This shift could lead to numerous positive outcomes for the economy and job market. However, it's crucial to address some existing challenges promptly to ensure this momentum is not lost. The potential for revitalization is there, but it hinges on timely action.
Read full article
via Forbes
Oil ends slightly up, trade choppy on report, denial of US attack plan on Venezuela
Investing.com2 hours ago
Oil ends slightly up, trade choppy on report, denial of US attack plan on Venezuela
NeutralFinancial Markets
Oil prices ended slightly higher amid a choppy trading session, influenced by a report regarding potential U.S. military action against Venezuela, which was subsequently denied. This situation highlights the ongoing volatility in the oil market, driven by geopolitical tensions and speculation. Investors are closely monitoring these developments as they can significantly impact oil supply and prices.
Read full article
via Investing.com
U.S. Natural Gas Rises on Winter Outlook, Strong LNG
The Wall Street Journal2 hours ago
U.S. Natural Gas Rises on Winter Outlook, Strong LNG
PositiveFinancial Markets
U.S. natural gas futures have seen a positive trend, rising for the third consecutive session as the market anticipates increased demand due to the upcoming winter weather. This uptick is significant as it reflects growing confidence in the energy sector, particularly with strong liquefied natural gas (LNG) exports. Investors are optimistic about the potential for higher prices and robust market activity in the colder months ahead.
Read full article
via The Wall Street Journal
Nvidia’s China Future Remains Unclear
Bloomberg2 hours ago
Nvidia’s China Future Remains Unclear
NeutralFinancial Markets
In a recent discussion on Bloomberg Tech, Amy Webb, CEO of Future Today Strategy Group, highlighted the ongoing technology tensions between the US and China following a meeting between their leaders. This conversation is crucial as it sheds light on the uncertain future of companies like Nvidia in the Chinese market, which could have significant implications for global tech dynamics.
Read full article
via Bloomberg
Trump says US, Canada will not restart trade talks
Investing.com2 hours ago
Trump says US, Canada will not restart trade talks
NegativeFinancial Markets
In a recent statement, former President Trump announced that the United States and Canada will not be resuming trade talks, a decision that could have significant implications for both economies. This development is concerning as it may hinder trade relations and economic growth in the region, affecting businesses and consumers alike.
Read full article
via Investing.com
Trump Denies Reports He’s Planning Strikes on Venezuela
Bloomberg3 hours ago
Trump Denies Reports He’s Planning Strikes on Venezuela
NeutralFinancial Markets
In a recent statement, former President Donald Trump denied reports suggesting that his administration is planning military strikes on Venezuela. This comes amid rising tensions as retired Army General Wesley Clark noted that the U.S. is applying pressure on Venezuelan President Nicolas Maduro, keeping him uncertain about potential military actions. The situation is significant as it highlights the ongoing geopolitical dynamics in Latin America and the U.S.'s approach to foreign policy.
Read full article
via Bloomberg
Latest from Financial Markets
Investing Heavily in AI as Models Improve: GoDaddy CEO
Bloombergan hour ago
Investing Heavily in AI as Models Improve: GoDaddy CEO
PositiveFinancial Markets
GoDaddy's CEO, Aman Bhutani, has announced an ambitious plan to transform the company through generative AI tools. By the end of this year, GoDaddy aims for 70% of its code to be AI-generated, showcasing a significant shift in how the company operates. This move not only highlights the growing importance of AI in the tech industry but also positions GoDaddy as a leader in innovation, potentially enhancing its services and customer experience.
Read full article
via Bloomberg
DTE Energy posts DTE Gas Company Q3 financial statements on company website
Investing.coman hour ago
DTE Energy posts DTE Gas Company Q3 financial statements on company website
NeutralFinancial Markets
DTE Energy has released its Q3 financial statements for DTE Gas Company on its official website. This update is significant as it provides stakeholders with insights into the company's financial health and operational performance during the third quarter, allowing investors and analysts to assess its progress and future outlook.
Read full article
via Investing.com
Bulova is selling an 'eye-catching' dive watch for just $280
TheStreetan hour ago
Bulova is selling an 'eye-catching' dive watch for just $280
PositiveFinancial Markets
Bulova has launched an eye-catching dive watch priced at just $280, making it an attractive option for watch enthusiasts. This watch not only boasts a stylish design but also features a secret element on the back, adding a unique twist that sets it apart from typical dive watches. This release is significant as it combines affordability with innovative design, appealing to both casual wearers and serious collectors.
Read full article
via TheStreet
GeneDx holdings CFO Feeley sells $52977 in stock
Investing.coman hour ago
GeneDx holdings CFO Feeley sells $52977 in stock
NeutralFinancial Markets
GeneDx Holdings' CFO, Feeley, has sold $52,977 worth of stock, which is a routine part of managing personal investments. Such transactions can often indicate the executive's confidence in the company's future or personal financial planning. While this sale might raise some eyebrows, it's important to remember that executives frequently buy and sell shares for various reasons.
Read full article
via Investing.com
BridgeBio Pharma director sells $13.2m in BBIO stock
Investing.coman hour ago
BridgeBio Pharma director sells $13.2m in BBIO stock
NegativeFinancial Markets
In a significant move, a director at BridgeBio Pharma has sold $13.2 million worth of BBIO stock, raising concerns among investors about the company's future. Such large stock sales by insiders can often signal a lack of confidence in the company's performance, leading to speculation and potential volatility in the stock price. This development is particularly noteworthy as it comes at a time when the biotech sector is facing various challenges, making it crucial for stakeholders to closely monitor the situation.
Read full article
via Investing.com
Core Scientific shareholders reject merger with CoreWeave, agreement terminated
Investing.coman hour ago
Core Scientific shareholders reject merger with CoreWeave, agreement terminated
NegativeFinancial Markets
Core Scientific shareholders have voted against the proposed merger with CoreWeave, leading to the termination of the agreement. This decision reflects the shareholders' concerns about the potential benefits of the merger and raises questions about the future direction of Core Scientific. The rejection of this merger could impact the company's growth strategy and its competitive position in the market.
Read full article
via Investing.com